U.S. Markets open in 8 hrs 49 mins

Cosmos Holdings, Inc. Adds Distinguished Member to Its Advisory Board to Fuel International Growth

CHICAGO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (COSM), an international pharmaceutical company, announced that it has added a new member to its advisory board.  Mr. Anastasios Tzikas is the president of several organizations including: Thessaloniki International Fair HELEXPO SA, Federation of Hellenic Information Technology & Communications (SEPE), and Technopolis Thessaloniki ICT Business Park. He is also one of the founders & former CEO of Singular Northern Greece SA, one of the largest software vendor and integrated IT solutions group in Greece and Balkans area.

“Anastasios Tzikas brings a wealth of expertise and experience to our company,” said Grigorios Siokas, Chief Executive Officer of Cosmos Holdings. “His tenure as former CEO of a listed multinational company and as president of well-recognized organizations makes him a great addition to our advisory board.  We are excited to welcome him to the Cosmos team and look forward to his insight and contribution to our strategy for healthcare IT solutions.

New advisory board member Anastasios Tzikas stated: “Cosmos Holding Inc. is a vibrant international company, with an emphasis on innovation and extroversion. It is therefore a major challenge for me to personally assist this company in integrating new technologies into its core business and developing synergies in the sectors of e-health and biotech.”

About Cosmos Holdings, Inc.

Cosmos Holdings Inc. is an international pharmaceutical company focused on identifying, acquiring, developing, and commercializing medicines to improve patients' lives and outcomes. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece & in Harlow, UK. More information is available at www.cosmosholdingsinc.com.


Except for historical information, this news release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve unknown risks, and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Important factors that might cause such differences are discussed in the Company's filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results could differ materially from those anticipated in these forward-looking statements, if new information becomes available in the future.

Investor Relations contact:
Steve Carr
312-780-7211 / scarr@dresnerco.com